FDA NDC Directory · JSON-LD · Markdown

Banzel

NDC 62856-584 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namerufinamide
Labeler / ManufacturerEisai Inc.
Marketing categoryNew Drug Application (innovator) · App NDA201367
Dosage form / routeSUSPENSION · ORAL
Active ingredientsRUFINAMIDE (40 mg/mL)
Marketing started20110303
Package count1

External sources

Source: openFDA. Public-domain (CC0).